Page last updated: 2024-10-27

furosemide and Leishmaniasis, Diffuse Cutaneous

furosemide has been researched along with Leishmaniasis, Diffuse Cutaneous in 1 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Leishmaniasis, Diffuse Cutaneous: A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Almeida-Amaral, EE1
Caruso-Neves, C1
Pires, VM1
Meyer-Fernandes, JR1

Other Studies

1 other study available for furosemide and Leishmaniasis, Diffuse Cutaneous

ArticleYear
Leishmania amazonensis: characterization of an ouabain-insensitive Na+-ATPase activity.
    Experimental parasitology, 2008, Volume: 118, Issue:2

    Topics: Adenosine Triphosphatases; Animals; Cation Transport Proteins; Dose-Response Relationship, Drug; Enz

2008